Literature DB >> 2611243

Human platelet factor 4 monomer-dimer-tetramer equilibria investigated by 1H NMR spectroscopy.

K H Mayo1, M J Chen.   

Abstract

As a function of protein concentration, proton NMR spectra of human platelet factor 4 (PF4) differ. Correlation with low-angle laser light scattering data has allowed identification of concentration-dependent NMR spectral changes to PF4 aggregation, with tetramers being the largest aggregates formed. Well-resolved aromatic ring proton NMR resonances were assigned to Tyr-60, His-I, and His-II in monomer, dimer, and tetramer states. Since Tyr-60 3.5 ring proton resonances are well resolved from state to state, estimation of fractional populations in each state was possible. By varying the PF4 concentration, changes in these populations when plotted according to the Hill equation show a bimolecular mechanism of aggregation which proceeds from monomers to tetramers through a dimer intermediate. Equilibrium constants for dimer association (KD) and tetramer association (KT) have been estimated as a function of pH and ionic strength. At pH 4, where KD and KT approach the same value, resonances associated with all three aggregate states are observed. Lowering the pH shifts the equilibrium to the monomer state, while raising the pH shifts the equilibrium to dimer and tetramer states. Analysis of the pH dependence of KD and KT suggests that electrostatic interactions, probably arising from Glu/Asp and Lys/Arg side chains, play a role in the binding process. Increasing the solvent ionic strength stabilizes the tetramer state especially at low pH, suggesting that intersubunit, repulsive electrostatic interactions probably between/among cationic side chains (Lys/Arg) attenuate the aggregation process. Information based primarily on histidine pKa values and photo-CIDNP 1H NMR data suggests that Tyr-60 and His-I, but not His-II, are significantly affected by the aggregation process.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2611243     DOI: 10.1021/bi00450a034

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  22 in total

1.  The human cytokine I-309 is a monocyte chemoattractant.

Authors:  M D Miller; M S Krangel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

2.  Homology modeling and molecular dynamics simulations of lymphotactin.

Authors:  J Xiong; J Lubkowski; R Nussinov
Journal:  Protein Sci       Date:  2000-11       Impact factor: 6.725

3.  Characterization of the chemokine CXCL11-heparin interaction suggests two different affinities for glycosaminoglycans.

Authors:  India C Severin; Jean-Philippe Gaudry; Zoë Johnson; Andreas Kungl; Ariane Jansma; Bernd Gesslbauer; Barbara Mulloy; Christine Power; Amanda E I Proudfoot; Tracy Handel
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

4.  Multiple native-like conformations trapped via self-association-induced hydrophobic collapse of the 33-residue beta-sheet domain from platelet factor 4.

Authors:  E Ilyina; K H Mayo
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

5.  Secondary structure of neutrophil-activating peptide-2 determined by 1H-nuclear magnetic resonance spectroscopy.

Authors:  K H Mayo; Y Yang; T J Daly; J K Barry; G J La Rosa
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

6.  Antimicrobial peptides from human platelets.

Authors:  Yi-Quan Tang; Michael R Yeaman; Michael E Selsted
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Analysis of hydrophobicity in the alpha and beta chemokine families and its relevance to dimerization.

Authors:  D G Covell; G W Smythers; A M Gronenborn; G M Clore
Journal:  Protein Sci       Date:  1994-11       Impact factor: 6.725

8.  Comparative studies of the interaction of human and bovine platelet factor 4 with heparin using histidine NMR resonances as spectroscopic probes.

Authors:  C J Talpas; L Lee
Journal:  J Protein Chem       Date:  1993-06

9.  Heparin binding to platelet factor-4. An NMR and site-directed mutagenesis study: arginine residues are crucial for binding.

Authors:  K H Mayo; E Ilyina; V Roongta; M Dundas; J Joseph; C K Lai; T Maione; T J Daly
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

10.  Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg.

Authors:  I Clark-Lewis; B Dewald; T Geiser; B Moser; M Baggiolini
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.